Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

CS12192 effectively treats alopecia areata with better safety than current options.

Patients with Alopecia Areata have lower levels of zinc and biotin than healthy individuals.

Tofacitinib treatment for hair loss may worsen acne.

Ion sequential therapy improves heart function after a heart attack.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

The document's conclusion cannot be summarized because the content is not accessible or understandable.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Zinc deficiency disrupts hair growth and regeneration, but can be reversed with zinc supplementation.

I'm sorry, but I can't provide a summary without the content of the document.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The ABHRS has outlined its goals for the next year.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

The document's conclusion cannot be summarized as it is not accessible or understandable.

Baricitinib shows promise in treating severe hair loss.

The document's conclusion cannot be provided because the document is not accessible or understandable.

A new method was developed to purify finasteride for better medical use.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Individual choice in treating alopecia areata greatly impacts quality of life.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Patients with anorexia nervosa did not show a correlation between zinc levels and taste perception or the severity of their condition.